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Abstract
Laminae I-III of the spinal dorsal horn contain many inhibitory interneurons that use GABA and/or glycine as a
neurotransmitter. Distinct neurochemical populations can be recognised among these cells, and these populations are likely
to have differing roles in inhibiting pain or itch. Quantitative studies in rat have shown that inhibitory interneurons account
for 25-40% of all neurons in this region. The sst2A receptor is expressed by around half the inhibitory interneurons in
laminae I-II, and is associated with particular neurochemically-defined populations. Although much of the work on spinal
pain mechanisms has been performed on rat, the mouse is now increasingly used as a model, due to the availability of
genetically altered lines. However, quantitative information on the arrangement of interneurons is lacking in the mouse, and
it is possible that there are significant species differences in neuronal organisation. In this study, we show that as in the rat,
nearly all neurons in laminae I-III that are enriched with glycine also contain GABA, which suggests that GABA-
immunoreactivity can be used to identify inhibitory interneurons in this region. These cells account for 26% of the neurons
in laminae I-II and 38% of those in lamina III. As in the rat, the sst2A receptor is only expressed by inhibitory interneurons in
laminae I-II, and is present on just over half (54%) of these cells. Antibody against the neurokinin 1 receptor was used to
define lamina I, and we found that although the receptor was concentrated in this lamina, it was expressed by many fewer
cells than in the rat. By estimating the total numbers of neurons in each of these laminae in the L4 segment of the mouse,
we show that there are around half as many neurons in each lamina as are present in the corresponding segment of the rat.
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Introduction
Laminae I-III of the dorsal horn contain a large number of
inhibitory interneurons that modulate sensory information before
this is transmitted to the brain and to other regions of the spinal
cord. It has been shown that in the rat these cells constitute ,25–
30% of the neurons in laminae I–II and 40% of those in lamina
III. Immunocytochemical studies suggest that they are all
GABAergic, with some also using glycine as a co-transmitter [1–
3]. Most of these cells give rise to axons that form axodendritic and
axosomatic synapses and generate postsynaptic inhibition, how-
ever, axons of some GABAergic neurons form axoaxonic synapses
that presynaptically inhibit primary afferents [4,5]. Several distinct
anti-nociceptive and anti-pruritic roles have been suggested for the
inhibitory interneurons [6–8], and it is likely that these are
performed by different functional populations. There have
therefore been many attempts to classify inhibitory interneurons
in laminae I–III, based on developmental, morphological,
electrophysiological or neurochemical criteria [2,9–14].
The somatostatin receptor sst2A is expressed at high levels in the
superficial dorsal horn of the rat, and is present on 13-15% of
neurons in laminae I-II [15–18]. We have provided both
anatomical and electrophysiological evidence that the receptor is
restricted to GABAergic cells [16,19], and we therefore estimate
that it is expressed by ,50% of the inhibitory interneurons in this
region [20]. Studies in the rat have indicated that four non-
overlapping neurochemical populations can be identified among
the inhibitory interneurons in these laminae, based on the
expression of galanin, neuronal nitric oxide synthase (nNOS),
neuropeptide Y (NPY) and parvalbumin [21–23]. Interestingly,
the sst2A receptor is present on virtually all of those that express
galanin or nNOS, but few of those that contain NPY and none of
the parvalbumin cells [20]. This indicates that the receptor is
associated with specific types of inhibitory interneuron in the
superficial dorsal horn.
Quantitative information concerning interneurons is important,
as it allows the sizes of different populations to be determined. It
also provides baseline data for studies of pathological states in
which interneurons may have been lost [8,24,25]. Although we
have quantitative data concerning interneuron numbers in the rat
[1,16,20,22] there is little corresponding information for the
mouse, which is increasingly used in pain research, because of the
availability of genetically altered lines. Significant differences
between rat and mouse have been reported, for example in the
pattern of expression of the TRPV1 receptor on nociceptive
primary afferents [26], and it is therefore not safe to assume that
the organisation of interneuron populations is the same in both
species. The first aim of this study was to determine whether the
proportions of neurons that are GABAergic in laminae I–III of the
mouse are the same as those previously reported for the rat [1] and
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whether, as in the rat, cells with high levels of glycine are also
GABA-immunoreactive [1,3]. We also tested whether the
expression pattern of sst2A is similar in the two species. Since the
distribution of neurokinin 1 receptor (NK1r) was used to define the
border between laminae I and II [27–29], we determined the
proportion of neurons that expressed NK1r, in order to allow
comparison with data from the rat, in which nearly half of the
neurons in lamina I are NK1r+ [16]. Finally, the stereological
method that we used allowed us to estimate the total number of
neurons in each of these laminae in the L4 segment of the mouse,
and compare this with corresponding data for the rat.
Materials and Methods
Ethics statement
All experiments were approved by the Ethical Review Process
Applications Panel of the University of Glasgow and were
performed in accordance with the UK Animals (Scientific
Procedures) Act 1986.
Animals and tissue processing
Eleven adult male C57Bl/6 mice of either sex, weighing 18–
30 g were deeply anaesthetised with pentobarbital (20 mg i.p.) and
perfused through the left ventricle with fixative. This consisted of
1% formaldehyde/2.5% glutaraldehyde for 4 mice, 4% formal-
dehyde/0.2% glutaraldehyde for 3 mice and 4% formaldehyde for
the remaining 4 animals. In all cases the formaldehyde was
prepared from paraformaldehyde immediately before use. Fol-
lowing perfusion fixation, the L4 segments were removed from all
animals and cut into 60 mm thick sections with a Vibratome.
Transverse sections were used for all parts of the study.
GABA and glycine immunoreactivity in laminae I-III
Sections from the 4 mice fixed with 1% formaldehyde/2.5%
glutaraldehyde were processed for post-embedding immunocyto-
chemistry [1]. The sections were treated for 30 mins with 1%
sodium borohydride to reduce free aldehyde groups. They were
then osmicated (1% OsO4 for 20 mins), dehydrated in acetone
and flat-embedded in Durcupan resin. From each of the 4 mice, 2
Vibratome sections were mounted onto blocks of cured resin and
trimmed such that the block face contained the whole of laminae
I-III on both sides. A series of 16 semithin sections, each 0.5 mm
thick, was cut and the 1st, 8th, 12th and 16th of these were stained
with toluidene blue. Three of the sections were processed for
immunocytochemical detection of GABA (6th section) or glial
fibrillary acidic protein (GFAP, 7th and 9th sections) [1,30]. They
were etched for 40 min in a saturated solution of sodium
hydroxide in ethanol, treated in 1% sodium metaperiodate to
remove osmium, and then incubated overnight at 4uC in primary
antibody against GABA (1:10,000) or GFAP (1:1000). After
rinsing, sections were incubated for 1 hour at room temperature in
biotinylated donkey anti-rabbit IgG (Jackson Immunoresearch,
West Grove, PA, USA; 1:500) and then for 1 hour in ExtrAvidin
peroxidase conjugate (Sigma, Poole, UK, catalogue number E-
2886; 1:1,000). They were then reacted with 0.05% 3,39-
diaminobenzidine in the presence of H2O2 for 15 minutes to
reveal peroxidase activity, and the reaction product was intensified
with 0.01% OsO4 for 5 minutes. For this part of the study
antibodies were diluted in phosphate buffered saline containing
0.5 M sodium chloride. Details of all the primary antibodies used
in this study are given in Table 1.
The physical disector method [31–33] was used to obtain an
unbiased sample of neurons from laminae I-III of the dorsal horn
in each series of semithin sections, as described previously [1]. The
reference (8th) section, which had been reacted with toluidene blue
was initially examined through a 206 objective lens on a Nikon
Optiphot II microscope equipped with a drawing tube. The
outline of the dorsal horn and boundaries between laminae I, II
and III (identified from the distribution of myelin) were drawn,
and the position of the lamina III-IV border was determined from
the Allen Brain Atlas (http://mousespinal.brain-map.org/). Neu-
ronal nuclei, which could readily be distinguished from oligoden-
drocytes by their pale appearance, were drawn. In most cases it
was possible to differentiate neurons from astrocytes, but if
necessary this was confirmed by examining the adjacent sections,
which had been immunostained for GFAP. The look-up (16th)
section was then examined, and any neuronal nuclei that were still
present were identified and excluded. The 12th section (also
stained with toluidene blue) was also examined to rule out the
possibility that two different nuclei in the same position on
reference and look-up sections were mistakenly counted as one [1].
In this way, all neurons for which the bottom surface of the
nucleus appeared between the reference and look-up sections was
included in the sample. These were then identified on the section
reacted for GABA, and the presence or absence of immunostain-
ing was recorded.
In order to test the hypothesis that glycinergic neurons in
laminae I–III were also immunoreactive for GABA [1,3], we
reacted pairs of serial semithin sections with GABA and glycine
antibodies, as described above. One pair from each mouse was
photographed, and the resulting digital images were overlaid.
Glycine-immunoreactive cells in laminae I–III were identified and
then examined for GABA immunoreactivity.
Sst2A and NK1r expression by neurons in laminae I-III
Sections from the 4 mice fixed with 4% formaldehyde were
incubated for 3 days at 4uC in a cocktail of primary antibodies
against sst2A, NeuN and NK1r and these were revealed by
overnight incubation at 4uC in species-specific fluorescent
secondary antibodies raised in donkey and conjugated to Alexa
488 (Invitrogen, Paisley, UK) or to Rhodamine Red or DyLight
649 (Jackson Immunoresearch). Secondary antibodies were used at
1:500 (Alexa 488 or DyLight 649 conjugates) or 1:100 (Rhoda-
mine Red conjugate). The sections were then incubated in DAPI,
to reveal cell nuclei. All antibodies used in this part of the study
were diluted in phosphate buffered saline containing 0.3 M
sodium chloride and 0.3% Triton-X100.
Two sections from each mouse were scanned with a Zeiss
LSM710 confocal microscope with Argon multi-line, 405 nm
diode, 561 nm solid state and 633 nm HeNe lasers. Images stacks
Table 1. Primary antibodies used in this study.
Antibody Species Dilution Source, catalogue number
GABA Rabbit 1:10,000* Sigma, A-2052
1:5000
Glycine Rabbit 1:50,000* DV Pow
GFAP Rabbit 1:1000 DAKO, Z0334
sst2A Guinea pig 1:2000 Gramsch, SS-870
NeuN Mouse 1:1000 Millipore, MAB377
NK1r Rabbit 1:10,000 Sigma, S8305
PKCc Rabbit 1:1000 Santa Cruz sc211
*dilutions used for post-embedding method
doi:10.1371/journal.pone.0078309.t001
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with a z-spacing of 1 mm were acquired through a 406 oil-
immersion lens, (numerical aperture 1.3) with the pinhole set to 1
Airey unit. Overlapping fields were scanned in order to cover the
whole of laminae I-III of the dorsal horn on one side. The image
stacks were viewed with Neurolucida for Confocal software
(MicroBrightField, Colchester, VT, USA) and analysed by using
a modification [34] of the optical disector technique [31,32,35–
37]. The outline of the grey matter was initially drawn, and the
locations of the boundaries between laminae I, II and III were
identified based on the distribution of immunoreactivity for NK1r
(which stains a dense plexus of dendrites in lamina I) and sst2A
(which stains dendrites throughout laminae I and II, see below).
The ventral border of lamina III was located as described above.
The 5th and 20th optical sections in the z-series were designated as
the reference and look-up sections. The NeuN and DAPI channels
were initially viewed for all optical sections in the z-stack, and
neuronal nuclei were identified by the presence of staining for
NeuN and DAPI. The locations of all neuronal nuclei that were
present on the reference section, or appeared in subsequent
sections, but had disappeared by the look-up section, were plotted.
The channels representing sst2A and NK1r were then switched on,
and the presence or absence of each type of immunostaining in the
neurons that were included in the disector sample was recorded.
Although the primary purpose of this part of the study was to
identify sst2A-expressing cells, we also counted those that possessed
the NK1r.
In the conventional disector method, the look-up and reference
sections are placed close together, so that none of the structures
being examined can fall between them. Because we carefully
examined all intervening optical sections to identify nuclei that lay
entirely between the reference and look-up sections, we were able
to place these sections further apart, and therefore obtain a larger
sample.
We also used these results to calculate the neuronal packing
density per 100 mm length of spinal cord for laminae I, II and III.
Since there was a variable degree of tissue shrinkage during the
processing of the Vibratome sections, the actual depth of tissue
analysed with the optical disector (15 mm) was equivalent to a
greater tissue depth from the original piece of fixed spinal cord. To
compensate for this, we multiplied the number of cells observed
within the 15 mm disector by a correction factor (the measured
thickness of the section in micrometres, obtained by scanning the
full thickness with the confocal microscope, divided by 60 mm)
[34]. To estimate the number of cells in each lamina within the
entire L4 segment, we measured the lengths of L4 in the 4 mice
that were used in this part of the analysis, as described previously
[34].
To confirm the laminar location of sst2A immunoreactivity,
sections from each of the 4 mice were incubated overnight in
antibodies against sst2A and PKCc, and then for 4 hours in
secondary antibodies conjugated to Alexa 488 or Rhodamine Red.
The PKCc antibody stains a plexus of dendrites that delineates the
inner half of lamina II in the rat [38]. These sections were then
scanned, together with a transmitted light image obtained with
dark-field illumination to reveal lamina II, which can be
recognised by its dark appearance, resulting from the lack of
myelin [39,40].
GABA and sst2A immunoreactivity
The relationship between GABA and sst2A immunostaining was
examined in sections from mice fixed with 0.2% glutaraldehyde/
4% formaldehyde, since glutaraldehyde fixation is required for
optimal retention of GABA [30,41]. Sections were treated for
30 mins with 1% sodium borohydride, and then incubated
overnight in antibodies against GABA and sst2A, which were
revealed with fluorescent secondary antibodies as described above.
Four dorsal horns were scanned with the confocal microscope
through the 406 oil-immersion lens from each of the 3 mice.
Because penetration of GABA immunostaining into Vibratome
sections is extremely limited [20,22,42,43], a very short z-series
that included the top surface of the section was scanned. Again,
overlapping scans were performed to include the whole of laminae
I-III for each dorsal horn.
Scans were analysed with Neurolucida for Confocal. The sst2A
channel was initially viewed and the outline of the dorsal horn,
together with the lamina II-III border were drawn, as described
above. The locations of all sst2A-immunoreactive cells that had
somata appearing on the upper cut surface of the Vibratome
section were plotted [20,22,42]. The GABA channel was then
viewed, and the presence or absence of GABA immunoreactivity
in each of the sst2A
+ cells was noted.
Antibody characterisation
The GABA and glycine antibodies have been shown not to
cross-react with the other amino acid, or with aspartate,
glutamate, taurine or b-alanine [44,45]. The GFAP antibody,
which was raised against GFAP extracted from cow spinal cord,
detects a single protein band of the appropriate size [46] and does
not label cells other than astrocytes [47]. The sst2A antibody was
raised against the C terminal 15 amino acids of the mouse
receptor, conjugated to keyhole limpet haemocyanin (KLH), and
staining is abolished by pre-incubation of this peptide (manufac-
turer’s specification). The NeuN antibody was raised against cell
nuclei obtained from mouse brain [48] and we have shown that it
labels all neurons, but no glial cells, in rat spinal cord [16]. The
NK1r antibody was raised against amino acids 393–407 of the rat
receptor coupled to KLH, and staining is absent in the brains of
mice lacking the NK1r [49]. The PKCc antibody is directed
against the C-terminus of the mouse protein. We have reported
that it stains identical structures to a well-characterised guinea-pig
antibody [22], and staining with the latter antibody is absent from
the brains of PKCc knock-out mice [50].
Results
GABA and glycine immunoreactivity in laminae I-III
The distribution of GABA immunoreactivity was very similar to
that reported in the rat [1,3]. Numerous immunoreactive cell
bodies were distributed throughout this region, and were also seen
in lower numbers in deeper laminae (Fig. 1a). Non-immunoreac-
tive cells could be readily distinguished by their uniform pale
appearance. The neuropil showed a relatively high level of
immunostaining, corresponding to dendrites of local interneurons
and GABAergic axons. Quantitative analysis of the disector
sample showed that in laminae I, II and III the proportions of
neurons that were GABA-immunoreactive were 31%, 24% and
38%, respectively (Table 2).
The pattern of glycine immunoreactivity was also very similar to
that reported in the rat [1,3]. In laminae I and II relatively few
cells were immunoreactive, but immunoreactive cells were
numerous in lamina III and in deeper parts of the grey matter
(Fig. 1c). However, unlike the situation with GABA immunostain-
ing, it was sometimes difficult to distinguish between weakly
positive and negative cells. This could be because unlike GABA,
which is only used as a neurotransmitter, glycine also has other
roles, and the metabolic pool of glycine may vary between
neurons. For this reason we did not attempt to quantify glycine-
immunoreactive cells. However, we found that the great majority
Inhibitory Interneurons in Mouse Dorsal Horn
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of cells in laminae I-III that had unequivocal glycine immunore-
activity were also GABA-immunoreactive (Fig 1b,c). Altogether,
we examined 110 glycine-immunoreactive cells in laminae I-II
(19–33/mouse, n= 4) and 203 cells in lamina III (33–62/mouse),
and found that 109 (99%) of those in laminae I-II and 195 (96%)
of those in lamina III were also GABA-immunoreactive.
Sst2A and NK1r immunoreactivity in laminae I-III
The distribution of staining for sst2A was very similar to that
reported in the rat [15,16], with a dense band of immunoreactive
cell bodies and dendrites occupying laminae I and II (Figs 2, 3).
Staining was much weaker elsewhere in the dorsal horn, although
a few immunoreactive cells were found in lamina III and
occasionally in deeper laminae. Comparison of immunoreactivity
for sst2A and PKCc showed that the ventral edge of the band of
intense sst2A staining corresponded to the ventral limit of the dense
plexus of PKCc, and this also matched the ventral border of
lamina II, as defined with dark-field microscopy [38,40].
Quantitative analysis with the optical disector method showed
that sst2A-immunoreactive cells accounted for 17.3%, 12.8% and
6.5% of the neurons in laminae I, II and III, respectively (Table 3).
As described previously in mouse [51–54] and rat [27–29,55–
57], NK1r-immunoreactivity was concentrated in lamina I, and
present at lower levels throughout the deep dorsal horn (laminae
III-VI), with very little in lamina II. NK1r-immunoreactivity was
detected on 19.3%, 4.8% and 5.9% of neurons in laminae I, II and
III, respectively (Table 3). Comparison of NK1r and sst2A
immunoreactivity in these sections showed that the NK1r antibody
labelled a population of neurons that was almost entirely separate
from those that were sst2A-immunoreactive (Fig 4). Altogether, 4
neurons that were double-labelled for both receptors were
observed (2 in lamina I, 1 each in laminae II and III), and these
represented 1.3% of the sst2A
+ and 1.9% of the NK1r+ cells in this
region.
Neuronal packing density and numbers of neurons in
each lamina
The packing densities of neurons in each lamina were
determined from the numbers of neurons included in each
Figure 1. GABA and glycine immunoreactivity in a 0.5 mm thick transverse section of the mouse dorsal horn. a shows the whole
mediolateral extent of the dorsal horn stained for GABA, while b and c show the medial part of the dorsal horn at higher magnification, in the same
section and in a section reacted for glycine, respectively. Many GABA-immunoreactive cell bodies are scattered throughout the dorsal horn, and
although these vary in intensity, they are clearly darker than the immunonegative cells, some of which are marked with asterisks in b. The dark
staining in the neuropil represents GABAergic axons and dendrites. Dashed lines show the ventral borders of laminae I, II and III. b and c are serial
semithin sections, so the same cells are visible. A few cells with relatively strong glycine immunoreactivity are visible (some marked with arrows) and
these are also GABA-immunoreactive. In addition, there are cells that are GABA- but not glycine-immunoreactive (two marked with arrowheads).
Scale bars = 100 mm.
doi:10.1371/journal.pone.0078309.g001
Table 2. Results of the quantitative analysis of GABA
immunoreactivity.
Lamina
Number of neurons
sampled
Percent
GABA-immunoreactive
I 46.5 30.5
(33–64) (24.2–32.8)
II 126.3 24.2
(100–148) (19.6–28.6)
III 116 37.6
(110–121) (32.2–42.6)
Mean values are shown with ranges in brackets (n = 4).
doi:10.1371/journal.pone.0078309.t002
Inhibitory Interneurons in Mouse Dorsal Horn
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disector (15 mm length) after correction for tissue shrinkage, and
are shown in Table 3. The mean length of the L4 segment in the 4
mice used for this part of the study was 1.45 mm (range 1.39 –
1.54 mm), and from this we estimate that the total numbers of
neurons in laminae I, II and III in this segment are 4466, 13,630
and 10,614, respectively (Table 3). These are between 50 and 60%
of the sizes of the neuronal populations in these laminae in the rat
L4 segment (7497, 27,465 and 21,928, respectively [34]).
Expression of sst2A by GABA-immunoreactive neurons in
laminae I-III
The total number of sst2A-immunoreactive neurons in laminae
I-II identified at the top surface of the sections from the mice fixed
with 0.2% glutaraldehyde/4% formaldehyde was 177 (range 51–
73, n= 3), and all of these were GABA-immunoreactive (Fig 5).
Thirty-seven sst2A
+ lamina III cells were seen in these sections
(range 11–14), and most of these (mean 92%, range 75–100%)
were also GABA-immunoreactive.
Discussion
The main findings of this study are that 24–38% of the neurons
in laminae I–III of mouse spinal cord are GABA-immunoreactive,
with some also showing glycine immunoreactivity, and that (as in
the rat) sst2A is restricted to inhibitory interneurons in laminae I–
II. However, although the laminar distribution of NK1r immu-
noreactivity is similar in both species, the number of immunore-
active cells is considerably lower in the mouse, with many fewer
lamina I neurons showing NK1r-immunoreactivity.
Inhibitory interneurons in laminae I–III
Inhibitory interneurons in the dorsal horn can use GABA and/
or glycine as neurotransmitters [58–62], and we have previously
reported that in the rat virtually all of the cells in laminae I–III that
Figure 2. Distribution of sst2A immunoreactivity in the mouse
dorsal horn. a: There is a dense band of immunostaining in laminae I
and II, with much lower levels elsewhere in the grey matter.
Immunoreactive cells (some marked with arrows) are scattered
throughout laminae I and II, and present at much lower density in
deeper laminae. The solid line shows the grey-white matter boundary
and the dashed line the border between laminae II and III. b–f: The
relationship between sst2A (green), PKCc (magenta) and the appearance
of the dorsal horn with dark-field illumination (DF). Note that although
scattered PKCc cells are present in lamina III, the ventral border of the
PKCc plexus (arrowheads) is at the same level as the ventral edge of
sst2A staining, and that this corresponds to the lamina II/III border as
seen with dark-field microscopy. All confocal images are from single
optical sections. Scale bar = 100 mm.
doi:10.1371/journal.pone.0078309.g002
Figure 3. Confocal images showing sst2A-immunoreactive
neurons in laminae I-II of the mouse dorsal horn in a transverse
section used for quantitative analysis. a: Part of the section
scanned to reveal sst2A (green). Several immunoreactive cells are visible,
and three of these are marked with arrows. b: The same field scanned
to reveal NeuN (blue) and the nuclear stain DAPI (red). c: In the merged
image, the dorsal border of the dorsal horn is shown with a solid line
and the boundary between laminae II and III with a dashed line. In this
image, neuronal nuclei appear magenta, while the nuclei of non-
neuronal cells are red. Note that most neurons in laminae I-II are not
sst2A-immunoreactive. The images were obtained from a single optical
section. Scale bar = 50 mm.
doi:10.1371/journal.pone.0078309.g003
Inhibitory Interneurons in Mouse Dorsal Horn
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have high levels of glycine (and are therefore likely to use glycine as
a transmitter) are also GABA-immunoreactive [1,3]. Although we
did not quantify glycine-immunoreactive cells in this study, we
found that nearly all of the cells in laminae I–III that were clearly
glycine-immunoreactive were also GABA-positive. This suggests
that, as in the rat, GABA is present in the great majority of
inhibitory interneurons in these laminae, with some of these
(particularly in lamina III) using glycine as a co-transmitter.
Expression of the neuronal glycine transporter GlyT2 is
required for glycinergic neurotransmission, and GlyT2 immuno-
reactivity is thought to be a reliable marker for glycinergic axons.
However, the transporter is not present at detectable levels in
neuronal cell bodies, and glycinergic neurons therefore cannot be
identified by using immunocytochemistry with antibodies against
GlyT2. Zeilhofer et al. [62] generated a bacterial artificial
chromosome transgenic mouse in which enhanced green fluores-
cent protein (EGFP) is expressed under control of the GlyT2
promotor, and used this to examine the distribution of glycinergic
neurons throughout the CNS. Although EGFP and glycine were
generally co-localised in cell bodies in regions known to contain
glycinergic neurons, there was a significant mismatch in the spinal
dorsal horn. In particular, laminae I and II contained very few
EGFP-positive cells, but several that were glycine-immunoreactive
and EGFP-negative. Since the Allen Brain Atlas shows some cells
with GlyT2 mRNA in laminae I-II of the mouse spinal cord, the
discrepancy between glycine and EGFP reported by Zeilhofer et
al. [62] may have resulted from lack of EGFP expression in
glycinergic neurons in this region. However, it is also possible that
some neurons that are not glycinergic have high levels of
(metabolic) glycine, and caution is therefore needed when
interpreting the results of glycine immunostaining.
If our assumption that nearly all glycinergic neurons in laminae
I-III are also GABA-immunoreactive is correct, then based on the
total numbers of neurons in each of these laminae (Table 3), and
the percentages that are GABA-immunoreactive, we can estimate
the proportions of neurons in this region that are inhibitory.
According to this estimate, inhibitory interneurons account for
30.1% of all neurons in laminae I-III, and 25.8% of those in the
superficial dorsal horn (laminae I-II). For comparison, the
corresponding values for the rat are 33.9% for the whole of
laminae I-III, and 29.9% for laminae I-II [1,34].
This quantitative data for inhibitory interneurons will allow the
proportion of these cells that belong to different sub-populations to
be determined. For example, we have found that in the rat,
GABAergic cells that contain nNOS, galanin or NPY account for
over half of all the inhibitory interneurons in laminae I-II [22].
These neurochemical classes differ both in their responses to
noxious stimulation [20] and also in their post-synaptic targets, with
at least some of the nNOS- and NPY-containing cells being
presynaptic to specific classes of projection neuron in laminae I and
III, respectively [39,63,64]. It has recently been shown in the mouse
that the parvalbumin-containing inhibitory neurons are involved in
presynaptic inhibition of low-threshold mechanoreceptive primary
Table 3. Proportions of neurons in laminae I-III that were sst2A- or NK1r-immunoreactive and numbers of neurons in each lamina.
Lamina
Number of
neurons sampled % sst2A % NK1r
Neuronal packing density
(per 100 mm)
Estimated total number of
neurons in L4
I 111 17.3 19.3 308 4466
(88–139) (13.6–19.8) (14.4–25.5) (255–346)
II 334 12.8 4.8 940 13,630
(314–370) (11.9–14.3) (2.4–8) (875–1000)
III 258 6.5 5.9 732 10,614
(236–283) (5–7.2) (2.5–9.2) (588–825)
Mean values are shown with ranges in brackets (n = 4). The estimated total number of neurons in L4 is based on the average length of the segment (1.45 mm) in these 4
mice.
doi:10.1371/journal.pone.0078309.t003
Figure 4. NK1r and sst2A in superficial dorsal horn. Confocal
image showing a single optical section through part of laminae I and
IIo, scanned to reveal NK1r (green) and sst2A (magenta). a: Two NK1r-
immunoreactive cell bodies (arrows) are visible in lamina I, surrounded
by a plexus of labelled dendrites. b: Several sst2A-immunoreactive cells
are visible in the same field (two shown with arrowheads). c: The
merged image shows that none of these cells is labelled with both
antibodies. Scale bar = 50 mm.
doi:10.1371/journal.pone.0078309.g004
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afferents [65], providing further evidence that neurochemically-
defined populations of inhibitory interneurons differ in function.
There are several mouse lines in which discrete populations of
inhibitory interneurons can be identified by expression of EGFP
[12,65–68], and the results of this study will make it possible to
determine directly the proportion of inhibitory interneurons that
are included in each of these populations. They will also allow an
accurate assessment of any neuronal loss that results from
pathological conditions such as spinal cord or peripheral nerve
injury [24,25,69], or from genetic alterations. For example, Ross et
al. [8] have reported that exaggerated itching in mice lacking the
transcription factor Bhlhb5 results from loss of inhibitory
interneurons in laminae I-II of the dorsal horn. In contrast, Wang
et al. [70] observed abnormal pain behaviours in mice in which
the testicular orphan nuclear receptor TR4 had been deleted, and
this was attributed to selective loss of excitatory interneurons from
the superficial dorsal horn, which would presumably result in an
abnormally high proportion of GABAergic neurons in this region.
Sst2A receptor expression
As in the rat, we found that all sst2A
+ neurons in laminae I-II
were GABA-immunoreactive [16]. From the relative numbers of
neurons in these laminae, we estimate that 13.9% of all superficial
dorsal horn neurons are sst2A-immunoreactive, and therefore that
,54% of the inhibitory interneurons in this region express the
receptor in the mouse. This is slightly higher than the
corresponding estimate for the rat (48%) [20].
There has been controversy concerning the actions of somato-
statin at the spinal level, with both pro- and anti-nociceptive effects
being reported [71-76]. Anti-nociceptive effects have generally
been seen with relatively high doses, which can cause significant
neurotoxicity, possibly by reducing local blood flow [75–77]. In
contrast, lower doses (up to 20 mg i.t. in rats) have resulted in signs
that were interpreted as resulting from a pro-nociceptive action
[71–73].
The Allen Brain Atlas shows high levels of mRNA for sst2, but
not for the other somatostatin receptors, in the mouse superficial
dorsal horn, and this is consistent with the distribution of sst2A
immunoreactivity reported in several studies in the rat [15–18,78]
and with the results of the present study. Sst1 receptors are also
found in the superficial laminae, but these are presumably located
on the central terminals of primary afferents (see below) [18].
Although one study has reported that the other sst2 splice variant
(sst2B) is present throughout the grey matter in rat spinal cord [78],
this does not match the distribution of sst2 mRNA in the mouse.
This could conceivably reflect a species difference, but it is more
likely that sst2B is only be expressed at very low levels. Application
of somatostatin to dorsal horn neurons results in hyperpolarisation
[79–81], and we have shown that this effect is restricted to
inhibitory interneurons in lamina II of the rat [19], consistent with
our immunocytochemical findings for sst2A in this species. These
observations suggest that the direct action of somatostatin on
dorsal horn neurons is mediated mainly or exclusively through
sst2A receptors. Somatostatin released from primary afferents or
local excitatory interneurons [82–84] acting on these receptors
should therefore result in disinhibition, and it is likely that this
accounts for the pro-nociceptive effects that have been reported
for intrathecal somatostatin [71–73]. However, both sst1 and sst2A
receptors are expressed by some primary afferents [17,18], and a
presynaptic action via these receptors probably contributes to the
anti-nociceptive actions of somatostatin administered intrathecally
or systemically [18,85].
Since sst2A is restricted to around half of the inhibitory
interneurons in the superficial dorsal horn, and is differentially
expressed by specific neurochemical types [20], this should allow
the roles of these cells to be investigated by using intrathecal
injections of saporin conjugated to somatostatin or its analogues to
ablate these cells selectively [86]. Studies with other peptide
conjugates of saporin have shown that while these selectively
destroy populations of spinal neurons, they do not appear to
damage primary afferents that express the corresponding receptors
[87–89].
NK1r expression in the mouse dorsal horn
Using the same NK1r antibody and a similar counting method,
we estimated that in laminae I, II and III of the rat, the
proportions of neurons that expressed the receptor were 45%, 6%
and 11%, respectively [16]. Although the result obtained for
lamina III is somewhat lower in the mouse, the most striking
difference is in lamina I, where NK1r-immunoreactive neurons
account for less than 20% of all neurons in the mouse (i.e. less than
half of the proportion seen in the rat). Lamina I of the rat spinal
cord has been shown to contain two different types of NK1r+ cell
that differ in size and receptor expression level: projection neurons
and interneurons [90,91]. The projection neurons, virtually all of
which belong to the spinoparabrachial tract [2], have relatively
Figure 5. Restriction of sst2A-immunoreactivity to GABAergic neurons in the superficial dorsal horn. a: A confocal scan (single optical
section) from the top surface of a Vibratome section that had been reacted to reveal sst2A (magenta) and GABA (green). Three sst2A-immunoreactive
cell bodies are marked with arrows, and there are many other labelled profiles, most of which are dendrites cut in cross section. b: The same field
scanned to reveal GABA. Several GABA-immunoreactive cell bodies can be seen and some of these are indicated with arrows or arrowheads. Many
cell bodies that are not GABA-immunoreactive are also present, and two are marked with asterisks. c: The merged image reveals that the sst2A-
immunoreactive cells are all immunostained for GABA, but that several GABA+ cells do not possess sst2A (two are indicated with arrowheads). Scale
bar = 20 mm.
doi:10.1371/journal.pone.0078309.g005
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large cell bodies and usually show strong NK1r immunoreactivity.
In contrast, the interneurons have significantly smaller cell bodies
and invariably show weak or moderate NK1r immunostaining.
Since virtually all NK1r+ cells in the superficial laminae lack
GABA immunoreactivity [29], these interneurons are thought to
be excitatory. Projection neurons are highly concentrated in
lamina I in the rat, but only make up around 5% of the neuronal
population, and ,80% of them are NK1r-immunoreactive [92].
We therefore estimate that 90% of the NK1r+ cells in lamina I of
the rat are excitatory interneurons, and that more than half of the
excitatory interneurons in this lamina possess the receptor.
There have apparently been few anatomical studies of lamina I
projection neurons in the mouse, but we have found that as in the
rat, many of these cells are strongly NK1r-immunoreactive (AJ
Todd, unpublished observations). Wang et al. [70] recently
reported that there were 100 retrogradely labelled lamina I cells
per twenty 25 mm thick transverse sections from lumbar spinal
cord in mice that had received large Fluorogold injections into the
lateral parabrachial area on one side. Based on the length of the
L4 segment in our study, this would equate to ,290 cells in the L4
segment. However, they included both contralateral and ipsilateral
cells, and we have shown that in the rat, most ipsilateral
spinoparabrachial cells project bilaterally, and that these account
for 30% of all lamina I spinoparabrachial neurons [92]. If a similar
arrangement is present in the mouse, then the number of lamina I
spinoparabrachial cells on one side would be approximately 220,
and since we estimate that there are ,4500 neurons in lamina I in
this segment, this would correspond to 5% of the neurons in this
lamina, a similar proportion to that estimated in the rat.
It is therefore likely that as in the rat, most of the NK1r-
immunoreactive cells in lamina I are interneurons, although the
proportion of these cells with the receptor is substantially lower
than in the rat.
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